期刊文献+

脾动脉阻断联合射频消融术治疗脾功能亢进的疗效观察 被引量:6

Percutaneous radiofrequency ablation of spleen together with splenic artery balloon block for the treatment of hypersplenism: observation of clinical effect
下载PDF
导出
摘要 目的总结脾动脉球囊阻断联合脾脏射频消融术(RFA)治疗肝硬化门静脉高压型脾功能亢进的有效性及经验。方法在脾动脉球囊阻断状态下对15例脾功能亢进患者行经皮穿刺脾脏RFA,RFA平均时间为(46.4±5.4)min。术后3 d、1周、1个月、3个月和6个月监测血常规,术后1个月复查腹部CTA。结果 1例患者术后出现左侧大量血性胸腔积液,给予止血及胸腔积液引流后好转,其余患者未发生严重并发症。RFA后1个月行腹部CTA检查示RFA毁损范围占脾脏总体积的比率为34.3%~71.8%,平均(56.20±13.09)%。术前血细胞计数示:白细胞为(3.88±1.75)×109/L,红细胞(4.06±0.37)×1012/L,血小板(48.14±11.33)×109/L。RFA术后1个月复查示:白细胞(5.62±1.61)×109/L,血小板(132.29±33.20)×109/L;与术前相比,血小板和白细胞显著升高(P〈0.05)。结论脾动脉球囊阻断联合RFA治疗肝硬化门静脉高压型脾功能亢进具有较高的安全性,且近期疗效可靠。 Objective To investigate the clinical effect and to summarize the experience of percutaneous radiofrequency ablation (RFA) of spleen together with splenic artery balloon block in treating hypersplenism due to cirrhosis and portal hypertension. Methods Under the situation of splenic artery occlusion with balloon, RFA of the spleen was performed in 15 patients with hypersplenism caused by cirrhosis and portal hypertension. The mean duration of RFA was (46.4±5.4) min. Routine blood tests were conducted at 3 days, one week, one, 3 and 6 months after the treatment, and abdominal CT angiography was performed one month after RFA. The results were analyzed. Results One patient developed massive bloody pleural effusion at left thorax three days after RFA, which was improved after hemostasis and thoracic drainage. No severe complications occurred in other patients. Abdominal CT angiography performed one month after RFA showed that the ablated extent by RFA was accounted for about 34.3%-71.8% proportion of the spleen, with a mean of (56.20 ±13.09)%. Preoperative blood tests indicated that the count of white blood cells, red blood corpuscles and blood platelets was (3.88±1.75)×109/L, (4.06±0.37) × 1012/L and (48.14± 11.33)×109/L, respectively. One month after RFA the count of white blood cells and blood platelets increased to (5.62±1.61) ×109/L and (132.29±33.20) ×109/L respectively. When compared with the preoperative data, the differences in the count of white blood cells and blood platelets were statistically significant (P〈0.05). Conclusion For the treatment of hypersplenism due to cirrhosis and portal hypertension, percutaneous radiofrequency ablation of spleen together with splenic artery balloon block is quite safe and this technique has satisfactory short-term effect.
出处 《介入放射学杂志》 CSCD 北大核心 2015年第5期405-408,共4页 Journal of Interventional Radiology
关键词 脾动脉 球囊阻断 射频消融 脾功能亢进 splenic artery balloon block radiofrequency ablation hypersplenism
  • 相关文献

参考文献12

二级参考文献47

共引文献76

同被引文献68

  • 1马鑫,刘新,郑涛,史涛坪,瓦斯里江.瓦哈甫,俞鸿凯,宋鹏,张旭.肾动脉低温灌注联合腹腔镜肾部分切除术处理复杂肾肿瘤的初步经验[J].微创泌尿外科杂志,2014,3(2):80-83. 被引量:17
  • 2李晓勇,刘新江,周百中,曹予文,杨战锋,杨红星,邵建梅.射频消融治疗肝癌115例报告[J].实用肝脏病杂志,2006,9(5):276-278. 被引量:9
  • 3王志军,王茂强,李功杰,段峰,王仲朴,刘凤永,宋鹏,汪维阳.介入微创治疗巨脾-脾亢新技术的实验研究[J].介入放射学杂志,2007,16(5):339-343. 被引量:4
  • 4吴宇旋,窦永充,张彦舫,孔建,徐坚民.经皮射频消融治疗巨大肝癌[J].介入放射学杂志,2007,16(11):755-758. 被引量:20
  • 5Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: A comparison of the safety of cryoablation and radiofrequency ablation.. European Journal of Radiology, 2014, 83(4):632-638.
  • 6Liu GJ, Ji Q, Moriyasu F, et al. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats.Ultrasound in Medicine and Biology, 2013, 39(11):2158-2165.
  • 7Yeung LWY, Guruge KS, Taniyasu S, et al. Profiles of perfluoroalkyl substances in the liver and serum of patients With liver cancer and cirrhosis in Australia. Ecotoxicology and Environmental Safety, 2013(96):139-146.
  • 8Gu J J, He XH, Li WT, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiologica, 2012, 53(8):862-867.
  • 9Terai S, Takami T, Yamamoto N, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived ceils and mesenchymal cells. Tissue engineering, Part B. Reviews, 2014, 20(3):206-210.
  • 10Zheng G, Zhang LJ, Zhong J, et al. Cerebral blood flow measured by arterial-spin labeling MRI: A useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. European Journal of Radiology, 2013, 82(11):1981-1988.

引证文献6

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部